Association of International Pharmaceutical Manufacturers
We bring together leading pharmaceutical companies with a shared goal: to ensure patients have access to innovative, high-quality, and safe medicines. We champion the highest standards in quality, ethics, and scientific development, contributing to the advancement of both the pharmaceutical industry and the broader healthcare system.
Association of International Pharmaceutical Manufacturers
We bring together leading pharmaceutical companies with a shared goal: to ensure patients have access to innovative, high-quality, and safe medicines. We champion the highest standards in quality, ethics, and scientific development, contributing to the advancement of both the pharmaceutical industry and the broader healthcare system.
Events & Announcements
News
Implementation and training
AIPM Code
Vision and Mission
We strive for the sustainable development of a pharmaceutical market where innovative, high-quality, and accessible medicines improve health and quality of life.
Vision
/ 01
Our mission is to unite leading international pharmaceutical companies in pursuit of excellence in quality, ethics, and innovation. We work in close collaboration with regulators, healthcare professionals, and medical communities to improve access to effective and safe treatments, support scientific progress, and contribute to the continuous improvement of the healthcare system.
This is a “living” document, regularly updated to reflect the Association’s experience, changes in Russian legislation, and global trends in ethical regulation.
Implementation and Scope
AIPM Code Training
The Code governs advertising and promotional activities related to pharmaceutical products, as well as the dissemination of information about health and diseases. It emphasizes the importance of open dialogue with the medical community and patient organizations to ensure timely and effective access to treatment.
Compliance with the Code is a mandatory requirement for all AIPM members. Upon joining the Association, companies confirm their full adherence to its provisions.